Skip to main content

Table 2 Secondary outcomes

From: Loxapine to control agitation during weaning from mechanical ventilation

 

Loxapine

Placebo

p Value

Ventilator-free days in first 14 days (SD)

5.8 (8.4)

5.5 (8.4)

0.9

Unplanned extubations, n (%)

6 (13)

7 (18)

0.5

Sedation resumption during the first 24 h, n (%)

8 (17)

17 (44)

0.01

Nosocomial pneumonia, n (%)

7 (15)

8 (21)

0.5

Mortality at 14 days, n (%)

1 (2)

2 (5)

0.6

Mortality at 6 weeks, n (%)

5 (10)

3 (8)

0.7